General Hospital PsychiatryVolume 71, July–August 2021, Pages 137-139Letter to the editorDue to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19Author links open overlay panelHiram Tendilla-Beltrán a b, Gonzalo Flores aShow moreShareCitehttps://doi.org/10.1016/j.genhosppsych.2021.05.005Get rights and contentPrevious article in issueNext article in issueKeywordsSARS-CoV-2NeuroinflammationAstrocytesMicrogliaNrf2BDNFRecommended articlesData availabilityNo data was used for the research described in the article.Cited by (0)View Abstract© 2021 Elsevier Inc. All rights reserved.